Asia-Pacific Injectable Drug Delivery Market – Industry Trends and Forecast to 2027

  • Pharmaceutical
  • Upcoming Report
  • Jun 2020
  • Asia-Pacific
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Asia-Pacific Injectable Drug Delivery Market, By Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Application (Autoimmune Disease, Hormonal Disorders, Orphan Diseases, Oncology, Others), Usage Pattern (Curative Care, Immunization, Other), Mode Of Administration (Skin, Circulatory/Muskoskeletal, Organs, Central Nervous System), End User (Hospitals and Clinics, Home Healthcare, Research Laboratories, Pharmaceutical and Biotechnological Companies, Others), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia- Pacific) Industry Trends and Forecast to 2027

Asia-Pacific Injectable Drug Delivery Market

Market Analysis and Insights: Asia-Pacific Injectable Drug Delivery Market

Injectable drug delivery market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 239.36 billion by 2027 growing at a CAGR of 11.45% in the above-mentioned forecast period. The growing demand of self- injection devices will help in driving the growth of the injectable drug delivery market.

Increasing occurrences of chronic diseases, surging levels of investment for the development of advanced technology, growth in the biologics market and launch of new product with technological advancements will likely to enhance the growth of the injectable drug delivery market in the forecast period of 2020-2027. On the other hand, growing demand for biosimilar and generic injectable will further boost various opportunities that will lead to the growth of the injectable drug delivery market in the above mentioned forecast period.

Infections associated with needle stick injuries and product recalls will likely to hamper the growth of the injectable drug delivery market in the above mentioned forecast period.

The growing preference of the alternative modes in drug delivery is posing a challenge to the injectable drug delivery market.

This injectable drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on injectable drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Asia-Pacific Injectable Drug Delivery Market Scope and Market Size

Injectable drug delivery market is segmented on the basis of type, application, usage pattern, mode of administration, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of type, the injectable drug delivery market is segmented into injectable drug delivery devices, injectable drug delivery formulation. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation.
  • Based on application, the injectable drug delivery market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented into rheumatoid arthritis, multiple sclerosis, Crohn’s disease, psoriasis and others. Hormonal disorders are further sub segmented into diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others.
  • Based on usage pattern, the injectable drug delivery market is segmented into curative care, immunization and other
  • On the basis of mode of administration, the injectable drug delivery market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system
  • Injectable drug delivery market has also been segmented based on the end user into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others
  • Based on distribution channel, the injectable drug delivery market is segmented into hospital pharmacy, pharmacy stores, direct tender and online pharmacy

Injectable Drug Delivery Market Country Level Analysis

Injectable drug delivery market is analysed and market size insights and trends are provided by country, type, application, usage pattern, mode of administration, end user and distribution channel as referenced above.

The countries covered in the injectable drug delivery market report are Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines, Rest of Asia- Pacific.

Asia-Pacific is expected to grow at the highest growth rate and is among third largest market in the forecast period of 2020 to 2027 with China leading the market due to the rising population along with changing lifestyle and adoption of advanced technologies.

The country section of the injectable drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Injectable Drug Delivery Market Share Analysis

Injectable drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to injectable drug delivery market.

The major players covered in the injectable drug delivery market report are Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, and Bespak among other domestic and Asia-Pacific players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Asia-Pacific Injectable Drug Delivery Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19